Latest Microsphere Stories
Corporate Pledge of $50,000 Supports Major Fund-raising Initiative to Expand Minimally Invasive Medicine Into New Areas of Discovery FAIRFAX, Va., Aug.
SAN DIEGO, June 29, 2011 /PRNewswire/ -- Suneva Medical, a privately-held aesthetic medical device company, today announced the expansion of its core aesthetics injectable business with approval from Health Canada to market Bellafill((TM)), its long lasting dermal filler for nasolabial folds or smile line correction.
For the first time, scientists have made star-shaped, biodegradable polymers that can self-assemble into hollow, nanofiber spheres, and when the spheres are injected with cells into wounds, these spheres biodegrade, but the cells live on to form new tissue.
AUSTIN, Texas, July 27 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX), the worldwide leader in multiplexed solutions, today announced the global launch of MAGPIXÂ®, an analytical instrument that is capable of performing up to 50 tests on a single sample and providing nearly 5,000 data points in under an hour.
EDMONTON, May 11 /PRNewswire/ - IMBiotechnologies Ltd.
New research in the FASEB Journal reports that fluorescent microspheres conjugated to cell surface molecules can detect early inflammation at the molecular level.
ATLANTA, Jan. 19 /PRNewswire/ -- Professor Franco Orsi, MD, Medical Director of the Unit of Interventional Radiology at the European Institute of Oncology was awarded The Symposium on Clinical Interventional Oncology 2010 Best Poster Award by Dr.
NEWNAN, Ga., Dec. 1 /PRNewswire/ -- CeloNova BioSciences, Inc., a provider of specialty surface treatments for medical devices and of specialty implants, today announced that President and Chief Executive Officer, Thomas A.
NEWNAN, Ga., Oct. 30 /PRNewswire/ -- CeloNova BioSciences today announced that the company is submitting to its European Notified Body a request for approval of its new, lime green, 2800 micron size Embozene(TM) Microsphere.
NEWNAN, Ga., Oct. 13 /PRNewswire/ -- CeloNova BioSciences, Inc. has received approval from its European regulatory body, the British Standards Institution, to expand the list of medical indications for which Embozene(TM) Microspheres may be used and to add a tenth size of the product.
- A trick or prank.